Product is distributed by:

Dako North America, Inc.
6392 Via Real
Carpinteria, CA 93013

+1 805 566 6655
+1 805 566 6688
www.dakousa.com
general@dako.com

Fisher Health Care
9999 Veterans Memorial Drive
Houston, TX 77038

+1 800 766 7000
+1 800 926 1166
www.fisherhealthcare.com

Erythrocyte-Lysing Reagent, Uti-Lyse™

These reagents provide complete and gentle lysis of erythrocytes. They are used following immunofluorescence staining of cells from whole blood or bone marrow, and prior to flow cytometric analysis. Due to the optical matching properties of the lysing buffer, the residual red cell debris does not need to be removed by centrifugation for most samples, making the reagents suitable for use in both 'wash' and 'no wash' staining procedures. In addition to lysis of red cells, Uti-Lyse™ fixes and stabilizes leucocytes. These reagents work with Dako antibodies, and are designed for use with most commercially available flow cytometers.

ProductSDS (Safety Data Sheet)Size
For In Vitro Diagnostic UseS3325 Ready-to-useErythrocyte Lysing Reagent A
250 tests, 25 mL
Product No. S332530
For In Vitro Diagnostic UseS3350 Ready-to-useErythrocyte Lysing Reagent A
500 tests, 50 mL
Product No. S335030

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.



Get in Touch with Dako in United States of America

  • Pathology Products, Flow Cytometry Products and Specific Proteins
    Dako North America, Inc.

    general@dako.com
    +1 805 566 6655
    +1 805 566 6688

    6392 Via Real
    Carpinteria, CA 93013

  • Flow Cytometry Products
    Fisher Health Care

    +1 800 766 7000
    +1 800 926 1166

    9999 Veterans Memorial Drive
    Houston, TX 77038

Detailed contact information

Submit an Inquiry

How would you like us to follow up?